Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized placebo-controlled study of vaginal arasertaconazole nitrate pessaries for vulvovaginal candidiasis
2009-016655-21Phase 2Completed
- Sponsor
- Ferrer
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Arasertaconazole nitrate in vulvovaginal candidiasis (VVC) (4 arms), sponsored by Ferrer. Primary endpoint: Efficacy. Started Feb 2010; status: completed.
02
Drugs
Arasertaconazole nitrate
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on 2009-016655-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016655-21.